AzTrials
AzTrials

Dental CariesEarly Phase 1NCT03089567

Comparison of the Salivary Levels of Streptococcus Mutans in Pediatric Patients With Early Childhood Caries After the Application of Silver Diamine Fluoride or 5% Sodium Fluoride Varnish

A Early Phase 1 study testing Sodium Fluoride and Silver diamine fluoride in people with Dental Caries, run by Yale University.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

Comparison of the salivary levels of Streptococcus mutans in pediatric patients with Early Childhood Caries after the application of Silver Diamine Fluoride or 5% Sodium Fluoride Varnish Read more about this study

Who is it for?
Ages 2 to 6 yearsHealthy volunteers can take part
Conditions the study is for
Dental Caries
What is being tested?
Sodium Fluoride and Silver diamine fluoride
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
No sites listed yet
Study dates
15 Sep 2017to 15 Jan 2018
Phase
Early Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 to 6 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • ASA I without prior history of dental restorations

Who cannot join

  • Patient with: special healthcare needs, xerostomia, complicated medical history (ASA II-VI)

About this study

Comparison of the salivary levels of Streptococcus mutans in pediatric patients with Early Childhood Caries after the application of Silver Diamine Fluoride or 5% Sodium Fluoride Varnish

Read the detailed description

Dental caries is the most common chronic disease in children (Benjamin, 2010). Studies suggest there is a positive correlation between bacterial titers of Streptococcus mutans and dental caries (Pannu et. al., 2013). National surveys suggest children 2 to 5 years old have 27.90% of primary teeth with caries. This number near doubles to 51.17% for children 6 to 11 years old (United States, National Health and Nutrition Examination Survey, 1999-2004). The American Academy of Pediatric Dentistry discusses this prevalence, in particular the finding of caries in young children, calling it early childhood caries (ECC), defined as "the presence of 1 or more decayed (noncavitated or cavitated lesions), missing (due to caries), or filled tooth surfaces in any primary tooth in a child 71 months of age or younger" or severe early childhood caries (S-ECC), defined as any sign of smooth surface caries in children younger than three years of age (AAPD, 2008). Oral health disparities also vary by race, ethnicity and socioeconomic status. Among children ages 3-5 years old, the prevalence of dental caries was significantly higher for non-Hispanic black individuals, 19%, compared to non-Hispanic white individuals, 11%. Furthermore, the prevalence of dental caries was nearly twice as high for Hispanic individuals, 26%, compared to non-Hispanic white individuals (Dye et. al., 2012).

The use of fluoride in dentistry has played a significant role in reducing the prevalence and severity of dental caries. Water fluoridation is considered to be one of the ten greatest achievements in public health of the twentieth century (CDC, 1999). Sodium Fluoride (SF) varnishes have become a mainstay in many pediatric dental practices. Despite their intended use as desensitizing agents, fluoride varnishes are used routinely to inhibit the demineralization of enamel, promote remineralization of enamel, and arrest early enamel carious lesions (Chu et. al, 2008, CDC 2001). Fluoride also interferes with cariogenic bacteria's ability to metabolize carbohydrates, reducing their acid production, and ability to adhere to tooth surfaces, possibly reducing their ability to initiate decay (CDC, 2001). The ability of fluoride, namely SF varnishes to effect bacterial counts of S. mutans has been described in a limited extent in the literature. Chandak describes fluoride varnish's ability to reduce S. mutans counts in dental plaque, suggesting another way fluoride aids in the reduction on dental caries (Chandak et. al., 2016). However, other studies do not support SF varnishes abilities to significantly reduce plaque S. mutans counts (Sajjan, et. al., 2013). Other studies attempt to examine the effects of fluoride varnishes' ability to effect S. mutans adherence and biofilm formation. In their study Chau et. al, described a reduction in S. mutans adhesion and subsequent biofilm accumulation in the presence of a number of commercially available SF varnishes (Chau et. al, 2014).

Similar to fluoride compounds, the antimicrobial effects of silver containing compounds have been used in dentistry for nearly a century. The mechanism behind these compounds' antibacterial effect is derived from the bioactive silver ion's ability to disrupt and irreversibly damage vital bacterial enzyme systems (Lansdown 2006). Despite their use internationally since the early twentieth century, silver containing compounds have fallen out of favor over time. More recently, silver diamine fluoride (SDF), currently approved by the FDA for treatment of dentinal hypersensitivity, has been shown to possess caries arresting properties. The clinical applications of SDF are seemly vast. Average operating room (OR) wait times vary between providers and can range from days to months depending on such factors as the provider's availability and resources, the patient's symptomatology, medical history, and extent of treatment. The patient population served at the Yale-New Haven Hospital Pediatric Dental Center is diverse both demographically and medically. Due to the demand and need for comprehensive dental treatment under general anesthesia, average OR wait times are 4 to 6 months. Indications for OR treatment include medically complex patients, uncooperative or pre-cooperative behavior profiles, patients with extensive and multi-quadrant decay patterns, and patients who do not meet selection criteria for sedation modalities. SDF's ability to arrest dental decay allows for patients on lengthy wait list awaiting treatment in the OR to avoid having their caries progress significantly. SDF is not a solution to caries; however it can be a useful tool in stemming the progression of decay for children awaiting surgical intervention under general anesthesia.

In light of SDF's ability to arrest dental caries, there is a question about its ability to impact the etiology of caries initiation, namely its effect on salivary S. mutans counts in the oral cavity. Few studies have investigated SDF's ability to alter bacterial counts in the oral environment in children. The application of SDF to human dentin blocks resulted in the development of fewer colony forming units of a number of cariogenic bacteria, including S. mutans, compared to the control group (Mei, 2013). Similar results were described in a study examining the effect of silver fluoride on S. mutans biofilm formation (Knight et. al., 2009). The impact of such an effect would be profound and could change caries management and prevention in the pediatric population (Duangthip, Chu et. al. 2016).

The increased interest and popularity of SDF has the potential to change the manner in which dental caries are treated in the pediatric population. Applications can prevent more invasive and costly need for general anesthesia, or other advanced behavior management techniques, or possibly prevent the progression of decay and avoid the loss of teeth (Chu, 2000). Furthermore, the potential ability of SDF to affect the bacterial composition of the oral environment, possibly reducing the initiation of caries has the exciting potential to be a ground breaking public health achievement.

Hypothesis

Application of SDF on carious teeth will show a higher decrease the salivary bacterial counts of S. mutans form baseline in 2-6 years old patients with ECC when compared to S. mutans levels after sodium fluoride varnish application and no treatment

Preliminary Research Design

Patient selection: Healthy 2-6 years old patients with ECC awaiting comprehensive dental treatment under general anesthesia

Inclusion criteria: ASA I without prior history of dental restorations

Exclusion criteria: Patient with: special healthcare needs, xerostomia, complicated medical history (ASA II-VI)

Experimental Groups:

  • 30 Patients that will receive 38% SDF application
  • 30 Patients that will receive 5% NaF varnish application
  • 30 Patient in Control group that will receive no treatment

Salivary collection: Salivary samples will be collected with SalivaBio Children's Swab.

A baseline S. mutans level will be obtained and quantified using Saliva-Check Mutans (GC America).

All carious teeth will receive a rubber cup and paste dental prophylaxis followed by either a topical application of 38% SDF, or 5% NaF varnish or no topical treatment.

Follow up: Further measurement of S. mutans levels will be obtained at 1, 3, 6 months after initial SDF, NaF varnish applications no treatment, without dental prophylaxis. Following salivary sample collections, re-application of SDF and NaF varnish will be applied to appropriate patient groups, and no further treatment provided to control group.

Conditions
Dental Caries
Being tested
Sodium Fluoride, Silver diamine fluoride
Keywords
Silver diamine Fluoride, Streptococcus mutans, Caries prevention, Fluoride
Medical subject headings
Dental Caries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Sodium FluorideDrug

    Also called Duraflor

    5% Sodium Fluoride Varnish used for dental caries prevention and desensitizer

  • Silver diamine fluorideDrug

    Also called Advantage Arrest

    38% Silver Diamine Fluoride used for dental caries prevention and desensitizer

Study groups in NCT03089567
Study groupRoleWhat they receive
CONTROL GROUPNo interventionPatients waiting for treatment under general Anesthesia without any intervention
Sodium Fluoride VarnishActive comparatorSodium Fluoride Varnish will be applied at 0,1,3 months Follow ups while waiting to receive dental treatment under general anesthesia
Receives: Drug: Sodium Fluoride
Silver Diamine FluorideExperimentalSilver Diamine Fluoride will be applied at 0,1,3 months Follow ups while waiting to receive dental treatment under general anesthesia
Receives: Drug: Silver diamine fluoride

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Salivary levels of Streptococcus mutans

    Salivary samples will be obtained with Children's Swab (SalivaBio) and S. Mutans level will be measured using Saliva-Check Mutans (GC America)

    Measured: Baseline

  2. Salivary levels of Streptococcus mutans

    Salivary samples will be obtained with Children's Swab (SalivaBio) and S. Mutans level will be measured using Saliva-Check Mutans (GC America)

    Measured: 1 month

  3. Salivary levels of Streptococcus mutans

    Salivary samples will be obtained with Children's Swab (SalivaBio) and S. Mutans level will be measured using Saliva-Check Mutans (GC America)

    Measured: 3 months

  4. Salivary levels of Streptococcus mutans

    Salivary samples will be obtained with Children's Swab (SalivaBio) and S. Mutans level will be measured using Saliva-Check Mutans (GC America)

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Mar 2017
  2. Study start15 Sep 2017
  3. Primary completion15 Jan 2018
  4. Study completion15 Jan 2018

Why it stopped: Study was not conducted. No participants were enrolled

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03089567
Sponsor's protocol ID
SMAHEN
Status last verified
Oct 2020
First submitted
20 Mar 2017
Last updated
23 Oct 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing Sodium Fluoride and Silver diamine fluoride in people with Dental Caries, run by Yale University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 23 Oct 2020. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Salivary levels of Streptococcus mutans (time frame: Baseline). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Oct 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in